share_log

Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.

Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.

炙手可热的IPOF股票将于10月14日停止交易。原因如下。
InvestorPlace ·  2022/09/20 11:17

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

InvestorPlace-股票市场新闻、股票建议和交易提示

Shares of special purpose acquisition company (SPAC) Social Capital Hedosophia VI (NYSE:IPOF) are falling back to their initial public offering price of $10 after Chamath Palihapitiya announced that he would return all funds to IPOF stock holders.

特殊目的收购公司(SPAC)的股份社会资本HedosophiaVI(纽约证券交易所股票代码:IPOF)在Chaath Palihapitiya宣布将把所有资金返还给IPOF股东后,股价回落至10美元的首次公开募股价格。

Palihapitiya explained his team evaluated more than 100 potential targets, but they ultimately stepped away due to two reasons. The first reason was valuation. He noted there were several interesting targets, although a deal "would have required us stretching on price or buying an inferior asset."

Palihapitiya解释说,他的团队评估了100多个潜在目标,但他们最终放弃了,原因有两个。第一个原因是估值。他指出,有几个令人感兴趣的目标,尽管交易“需要我们提高价格或购买劣质资产”。

The second reason was the volatile state of the market. Several company's management teams were hesitant to go public in a downturn year ravaged by inflation, interest rate hikes and supply chain issues.

第二个原因是市场的动荡状态。在通胀、加息和供应链问题肆虐的经济低迷之年,公司的几个管理团队对上市犹豫不决。

IPOF Stock Fails to Find a Target

IPOF股票找不到目标

Now, IPOF is set to return capital to its shareholders by Oct. 14, the deadline to find a target. Furthermore, it seems the hype around SPACs has cooled off. Palihapitiya isn't alone, though. More than 600 SPACs that hold a combined $174 billion are nearing deadlines to find a target over the next 16 months. These may find a fate similar to IPOF if no target is found.

现在,IPOF计划在10月14日之前向股东返还资金,这是寻找收购目标的最后期限。此外,围绕SPAC的炒作似乎已经降温。不过,帕里哈皮蒂亚并不孤单。600多家SPAC总共持有1,740亿美元,它们正在接近最后期限,希望在未来16个月找到目标。如果找不到目标,它们可能会发现类似于IPOF的命运。

On the other hand, the billionaire investor found success with some of his other SPACs. He successfully took companies like Opendoor (NASDAQ:OPEN), SoFi (NASDAQ:SOFI) and Clover Health (NASDAQ:CLOV) public. Still, all three of these companies are down by more than 40% year-to-date (YTD), with OPEN having the greatest YTD loss of 75%. The large losses on these former SPACs may have scared off potential targets of IPOF.

另一方面,这位亿万富翁投资者在他的一些其他SPAC上取得了成功。他成功地将像这样的公司OpenDoor(纳斯达克:开放),SOFI(纳斯达克:SOFI)和三叶草健康(纳斯达克:CLOV)公众。尽管如此,这三家公司今年迄今的跌幅都超过了40%,其中Open的YTD跌幅最大,为75%。这些前SPAC的巨额亏损可能吓跑了IPOF的潜在目标。

Palihapitiya noted his opinion on SPACs has remained unchanged since his first deal was signed. He views them as "just one of many tools in our toolkit to support companies as they enter subsequent stages of growth."

Palihapitiya指出,自他签署第一笔交易以来,他对SPAC的看法一直没有改变。他认为它们只是“我们工具箱中支持公司进入后续成长阶段的众多工具之一。”

In the meantime, Palihapitiya will focus on targets for his two remaining Bio 2.0 SPACs. Four Bio 2.0 SPACs were launched, while two have already found targets in the form of ProKidney (NASDAQ:PROK) and Akili (NASDAQ:AKLI). In an earlier interview, he disclosed that Social Capital had made $750 million from SPACs, roughly doubling their initial investment.

与此同时,Palihapitiya将专注于他剩下的两个Bio 2.0 SPAC的目标。发射了四个Bio 2.0空间委员会,其中两个已经找到了以原肾(纳斯达克:PROK)和阿基里(纳斯达克:阿克利)。在早些时候的一次采访中,他透露社会资本从SPAC中获得了7.5亿美元,大约是他们最初投资的两倍。

On the date of publication, Eddie Pan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

截至发稿之日,潘石屹并未(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点,以InvestorPlace.com为准出版指南.

Eddie Pan specializes in institutional investments and insider activity. He writes for InvestorPlace's Today's Market team, which centers on the latest news involving popular stocks.

埃迪·潘专门从事机构投资和内部活动。他为InvestorPlace的今日市场团队撰稿,该团队主要关注与热门股票有关的最新消息。

The post Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here's Why. appeared first on InvestorPlace.

红火的IPOF股票将于10月14日停止交易。原因如下。最先出现在InvestorPlace上。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发